Reference page — cumulative record through Monday, October 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Admidio
Product reference — Admidio by Admidio · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 27 | 27 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 6.5 | .0027 | 0 | 8 | 18 | 1 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▁▁▁█▁▄
| Month | New CVEs |
|---|---|
| 2026-05 | 1 |
| 2026-06 | 0 |
| 2026-07 | 0 |
| 2026-08 | 18 |
| 2026-09 | 1 |
| 2026-10 | 7 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-69091 | 8.7 | 48.3 | HIGH | — | 2026-08-03 |
| CVE-2026-82655 | 8.7 | 45.5 | HIGH | — | 2026-08-30 |
| CVE-2026-82657 | 8.7 | 37.8 | HIGH | — | 2026-08-30 |
| CVE-2026-82656 | 2.1 | 36.5 | LOW | — | 2026-08-30 |
| CVE-2026-69092 | 6.9 | 30.0 | MEDIUM | — | 2026-08-03 |
| CVE-2026-47231 | 8.1 | 27.0 | HIGH | — | 2026-08-12 |
| CVE-2026-47226 | 6.5 | 26.8 | MEDIUM | — | 2026-08-12 |
| CVE-2026-69090 | 6.9 | 26.4 | MEDIUM | — | 2026-08-03 |
| CVE-2026-47227 | 6.5 | 24.1 | MEDIUM | — | 2026-08-12 |
| CVE-2026-47233 | 6.5 | 22.5 | MEDIUM | — | 2026-08-12 |
| CVE-2026-82658 | 5.3 | 21.7 | MEDIUM | — | 2026-08-30 |
| CVE-2026-47230 | 6.5 | 21.2 | MEDIUM | — | 2026-08-12 |
| CVE-2026-109329 | 8.5 | 19.7 | HIGH | — | 2026-10-12 |
| CVE-2026-111916 | 6.9 | 18.0 | MEDIUM | — | 2026-10-17 |
| CVE-2026-69094 | 5.3 | 17.1 | MEDIUM | — | 2026-08-03 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-111914 | 7.1 | 14.6 | HIGH | — | 2026-10-17 |
| CVE-2026-111916 | 6.9 | 18.0 | MEDIUM | — | 2026-10-17 |
| CVE-2026-111913 | 5.3 | 7.3 | MEDIUM | — | 2026-10-17 |
| CVE-2026-111912 | 7.1 | 7.2 | HIGH | — | 2026-10-17 |
| CVE-2026-109327 | 5.1 | 10.1 | MEDIUM | — | 2026-10-12 |
| CVE-2026-109328 | 5.3 | 9.2 | MEDIUM | — | 2026-10-12 |
| CVE-2026-109329 | 8.5 | 19.7 | HIGH | — | 2026-10-12 |
| CVE-2026-53760 | 5.2 | 5.6 | MEDIUM | — | 2026-09-04 |
| CVE-2026-82658 | 5.3 | 21.7 | MEDIUM | — | 2026-08-30 |
| CVE-2026-82657 | 8.7 | 37.8 | HIGH | — | 2026-08-30 |
| CVE-2026-82655 | 8.7 | 45.5 | HIGH | — | 2026-08-30 |
| CVE-2026-82656 | 2.1 | 36.5 | LOW | — | 2026-08-30 |
| CVE-2026-47229 | 5.4 | 2.8 | MEDIUM | — | 2026-08-12 |
| CVE-2026-47233 | 6.5 | 22.5 | MEDIUM | — | 2026-08-12 |
| CVE-2026-47232 | 4.3 | 2.5 | MEDIUM | — | 2026-08-12 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Admidio — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
